-
August 23: The Week in Cancer News
Early immunotherapy may make more liver cancer patients eligible for surgery, and the FDA approves a new use for a lung cancer treatment.
by Kevin McLaughlin
-
August 16: The Week in Cancer News
Even small amounts of alcohol can increase cancer mortality risk, and research explores the role of weight-loss drugs in preventing cancer.
by Marci A. Landsmann
-
August 9: The Week in Cancer News
More endometrial cancer patients can now receive an immunotherapy, and taking aspirin regularly may help some people reduce their risk for colorectal cancer.
by Thomas Celona
-
August 2: The Week in Cancer News
Blood test approval widens access to colorectal cancer screening option, and language barriers interrupt cancer care before it starts.
by Eric Fitzsimmons
-
July 26: The Week in Cancer News
Double mastectomy doesn’t lead to a survival advantage over lumpectomy or single mastectomy, and research explores hearing loss linked to cisplatin.
by Marci A. Landsmann
-
July 19: The Week in Cancer News
Education about mammography is linked to reduced screening for women in their 40s, and pancreatic cancer discovery could lead to new treatments.
by Kevin McLaughlin
-
July 12: The Week in Cancer News
Standard screening may not catch endometrial cancer in Black women, and a cancer patient receives a voice box transplant for the first time.
by Thomas Celona
-
July 5: The Week in Cancer News
Neuropathy may be prevented with an exercise program, and prostate cancer screening standards may not be appropriate for transgender women taking estrogen.
by Eric Fitzsimmons
-
June 28: The Week in Cancer News
Acupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
by Marci A. Landsmann
-
June 21: The Week in Cancer News
Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
by Kevin McLaughlin
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona